Top

Published in:

01-12-2017 | Debate Article

PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro

Authors: Jamshid Maddahi, MD, FACC, FASNC, René R. Sevag Packard, MD

Published in: Journal of Nuclear Cardiology | Issue 6/2017

Excerpt

Positron emission tomography (PET) myocardial perfusion imaging (MPI) has been performed for the better part of 3 decades. Initially limited to academic centers and viewed with skepticism, it has gained greater acceptance as a test with improved ability to detect coronary artery disease (CAD) and improve patient risk stratification. Here, we will review how PET fares better than single-photon emission-computed tomography (SPECT) by comparing technical and radiotracer characteristics as well as clinical data. …

Maddahi J, Packard RR. Cardiac PET perfusion tracers: Current status and future directions. Semin Nucl Med 2014;44:333-43.CrossRefPubMedPubMedCentral

Maddahi J. Properties of an ideal PET perfusion tracer: New PET tracer cases and data. J Nucl Cardiol 2012;19:S30-7.CrossRefPubMed

Maddahi J, Udelson J, Heller GV, Lazewatsky J, Orlandi C. The first phase 3 international multicenter clinical trial of Flurpiridaz F 18, a new radiopharmaceutical for PET Myocardial perfusion imaging. J Nucl Cardiol 2015; Abstract.

Maddahi J, Huang SC, Schiepers C, Bengel F, Czernin J, Schelbert HS, et al. Same day rest-stress protocols for PET imaging with the new F-18 labeled BMS747158 myocardial perfusion tracer. J Nucl Med 2009;50:1173.

Berman DS, Maddahi J, Tamarappoo BK, Czernin J, Taillefer R, Udelson JE, et al. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: Flurpiridaz F 18 positron emission tomography. J Am Coll Cardiol 2013;61:469-77.CrossRefPubMed

Slomka PJ, Berman DS, Germano G. New cardiac cameras: Single-photon emission CT and PET. Semin Nucl Med 2014;44:232-51.CrossRefPubMed

Kaster T, Mylonas I, Renaud JM, Wells GA, Beanlands RS, deKemp RA. Accuracy of low-dose rubidium-82 myocardial perfusion imaging for detection of coronary artery disease using 3D PET and normal database interpretation. J Nucl Cardiol 2012;19:1135-45.CrossRefPubMed

Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, et al. Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med 2010;51:1592-9.CrossRefPubMedPubMedCentral

Knuuti J. Integrated positron emission tomography/computed tomography (PET/CT) in coronary disease. Heart 2009;95:1457-63.CrossRefPubMed

10.

Einstein AJ. Effects of radiation exposure from cardiac imaging: How good are the data? J Am Coll Cardiol 2012;59:553-65.CrossRefPubMedPubMedCentral

11.

Maddahi J, Czernin J, Lazewatsky J, Huang SC, Dahlbom M, Schelbert H, et al. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: Dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med 2011;52:1490-8.CrossRefPubMed

12.

Maddahi J, Bengel F, Czernin J, Crane P, Dahlbom M, Schelbert, HS, et al. Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing 2-day rest-stress PET myocardial perfusion imaging. J Nucl Cardiol. 2015 (in press).

13.

Maddahi J, Lazewatsky J, Udelson J, Orlandi C. Radiation dose to patients in a phase 3 trial of Flurpiridaz F18, a new radiopharmaceutical for PET Myocardial Perfusion Imaging. J Nucl Cardiol 2014; abstract.

14.

Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: A bivariate meta-analysis. Circ Cardiovasc Imaging 2012;5:700-7.CrossRefPubMed

15.

Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease?: A systematic review and meta-analysis. J Am Coll Cardiol 2012;60:1828-37.CrossRefPubMed

16.

Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: Comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006;13:24-33.CrossRefPubMed

17.

Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging 2010;3:623-40.CrossRefPubMed

18.

Dorbala S, Vangala D, Sampson U, Limaye A, Kwong R, Di Carli MF. Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: A 82Rb PET/CT study. J Nucl Med 2007;48:349-58.PubMed

19.

Bengel FM. Leaving relativity behind: Quantitative clinical perfusion imaging. J Am Coll Cardiol 2011;58:749-51.CrossRefPubMed

20.

Cremer P, Hachamovitch R, Tamarappoo B. Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease. Semin Nucl Med 2014;44:320-9.CrossRefPubMedPubMedCentral

21.

Fiechter M, Ghadri JR, Gebhard C, Fuchs TA, Pazhenkottil AP, Nkoulou RN, et al. Diagnostic value of 13 N-ammonia myocardial perfusion PET: Added value of myocardial flow reserve. J Nucl Med 2012;53:1230-4.CrossRefPubMed

22.

Naya M, Murthy VL, Taqueti VR, Foster CR, Klein J, Garber M, et al. Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography. J Nucl Med 2014;55:248-55.CrossRefPubMedPubMedCentral

23.

Packard RR, Huang SC, Dahlbom M, Czernin J, Maddahi J. Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET. J Nucl Med 2014;55:1438-44.CrossRefPubMedPubMedCentral

24.

Ben-Haim S, Murthy VL, Breault C, Allie R, Sitek A, Roth N, et al. Quantification of Myocardial perfusion reserve using dynamic SPECT imaging in humans: A feasibility study. J Nucl Med 2013;54:873-9.CrossRefPubMedPubMedCentral

25.

Kay J, Dorbala S, Goyal A, Fazel R, Di Carli MF, Einstein AJ, et al. Influence of sex on risk stratification with stress myocardial perfusion Rb-82 positron emission tomography: Results from the PET (Positron Emission Tomography) Prognosis Multicenter Registry. J Am Coll Cardiol 2013;62:1866-76.CrossRefPubMed

26.

Chow BJ, Dorbala S, Di Carli MF, Merhige ME, Williams BA, Veledar E, et al. Prognostic value of PET myocardial perfusion imaging in obese patients. JACC Cardiovasc Imaging 2014;7:278-87.CrossRefPubMed

27.

Herzog BA, Husmann L, Valenta I, Gaemperli O, Siegrist PT, Tay FM, et al. Long-term prognostic value of 13 N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.CrossRefPubMed

28.

Fukushima K, Javadi MS, Higuchi T, Lautamaki R, Merrill J, Nekolla SG, et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med 2011;52:726-32.CrossRefPubMed

29.

Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 2011;58:740-8.CrossRefPubMed

30.

Dorbala S, Di Carli MF. Cardiac PET perfusion: Prognosis, risk stratification, and clinical management. Semin Nucl Med 2014;44:344-57.CrossRefPubMedPubMedCentral

31.

Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 2011;124:2215-24.CrossRefPubMedPubMedCentral

32.

Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 2012;126:1858-68.CrossRefPubMedPubMedCentral

33.

Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 2015;131:19-27.CrossRefPubMed

Title: PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro
Authors: Jamshid Maddahi, MD, FACC, FASNC
René R. Sevag Packard, MD
Publication date: 01-12-2017
Publisher: Springer US
Published in: Journal of Nuclear Cardiology / Issue 6/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-015-0300-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2017

And in the end…

PET measurements of myocardial blood flow post myocardial infarction: Relationship to invasive and cardiac magnetic resonance studies and potential clinical applications

Responsible growth of nuclear cardiology in Spain

American perspective: Comparing the AHA/ACC and ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Nuclear cardiology in the literature: A selection of recent, original research papers

Incidental extra-cardiac findings on 13NH3 myocardial perfusion PET/CT

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page